Efficacy and safety of Rubus occidentalis extract on serum cholesterol

Efficacy and safety of Rubus occidentalis extract on serum cholesterol; A 12 week, randomized, double-blind, placebo-controlled clinical trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003497

Enrollment

100

Registered

2019-02-12

Start date

2018-06-25

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Test supplement: Rubus occidentalis extract (750 mg/day) Placebo supplement: Placebo 12-week, 4 tab/day, twice a day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 200 mg/dl = cholesterol = 249 mg/dl or 130 = LDL-cholesterol = 170 mg/dl

Exclusion criteria

Exclusion criteria: 1) treatment with hypolipidemic drugs within the past 3 months 2) those who receive treatment, rehabilitation, or inpatient treatment for heart disease or central nervous system disease 3) Creatinine level more than 2 times the upper limit of the normal range 4) ALT or AST level more than 3 times the upper limit of the normal range 5) uncontrolled diabetes, hypertension, or thyroid disease

Design outcomes

Primary

Measure	Time frame
Total cholesterol;LDL-cholesterol;HDL-cholesterol	—

Secondary

Measure	Time frame
Triglyceride;Apolipoprotein A?;Apolipoprotein B	—

Countries

Korea, Republic of

Contacts

Public ContactSoo-Hyun Park

Chonbuk National University Hospital

shpark@jbctc.org+82-63-259-3048

Outcome results